Sector: Pharmaceuticals & Biotechnology

Small Cap

Bliss GVS Pharma Share Price

Bliss GVS Pharma Ltd.

₹213.80

-11.27(-5.01%)

Trade Now

24th Feb 2026 | 3:28 PM

NSE : BLISSGVS

Open Free Demat Account

Bliss GVS Pharma Performance

Price Movement

₹213.80

₹205.55

₹225.07

↘ Today's Low↗ Today's High

1 Year Performance

₹213.80

₹108.12

₹243.90

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹225.07

Low₹205.55

Open at₹225.00

Prev Close₹225.07

Volumes38.77 L

Avg Price₹216.88

Lower Circuit₹180.06

Upper Circuit₹270.08

Historical Performance

3M High₹243.90

3M Low₹140.80

1 Yr High₹243.90

1 Yr Low₹108.12

3 Yr High₹243.90

3 Yr Low₹69.20

5 Yr High₹243.90

5 Yr Low₹66.10

Bliss GVS Pharma Fundamentals

Market Cap

Above industry Median

2,227.70 Cr.

PE Ratio (TTM)

Below industry Median

20.40

Dividend Yield

Below industry Median

0.50

Net Profit TTM

83.0% incr over last year

109.09

Net Profit Growth

83.0% incr over last year

109.09

PEG Ratio

Above industry Median

0.20

ROE

2.8% incr over last year

8.02

Operating Revenue TTM

868.11

Operating Revenue Growth

7.2% incr over last year

Book Value

Below industry Median

MFI

MFI Overbought

75.34

RSI

RSI Overbought

70.34

EPS (TTM)

8.02

Debt to Equity

0.07

Face Value

Operating Profit Margin Qtr.

14.97

Operating Profit Qtr.

34.79

Net Profit Qtr.

23.27

Operating Revenue Qtr.

218.25

PB Ratio

Bliss GVS Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	164.68	190.23	163.36	156	179.59
Operating Expense	137.83	172.21	130.60	142.27	153.86
Operating Profit	26.85	18.02	32.77	13.73	25.73
Depreciation	7.80	7.69	7.68	7.43	6.96
Interest	1.48	2.71	5.11	1.30	0.67
Tax	6.68	8.66	9.51	2.90	8.72
Net Profit	18.61	24.79	21.05	11.45	21.05

Bliss GVS Pharma Technicals

Bliss GVS Pharma Ltd. EMA & SMA

₹213.80

-11.27 (-5.01%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹224.4

Day EMA10 ₹218.4

Day EMA12 ₹215.6

Day EMA20 ₹205.8

Day EMA26 ₹200.2

Day EMA50 ₹186.6

Day EMA100 ₹174.2

Day EMA200 ₹162.5

Bliss GVS Pharma Support and Resistance

Resistance

First Resistance₹228.41

Second Resistance₹231.74

Third Resistance₹236.70

Support

First Support₹220.12

Second Support₹215.16

Third Support₹211.83

Technical Indicators

Day RSI70.34

Day MFI75.34

Day ADX39.03

Day Commodity Channel Index73.30

William-28.31

Day MACD15.38

Day MACD Signal Line13.42

Day ATR11.68

Day ROC12539.54

Day ROC2138.90

Bliss GVS Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	34.8	35.1	35.3	35.4	35.4	35.4
FII	12.1	13.5	13.2	12.6	13.3	14.5
DII	6.6	6.6	6.5	6.6	5.9	5.8
Public	46.5	44.8	45	45.4	45.4	44.3

Bliss GVS Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	4.04 L	11.71 L	34.49%
Week	8.99 L	45.05 L	19.96%
1 Month	10.95 L	41.71 L	26.24%
6 Month	6.24 L	35.28 L	17.68%

Bliss GVS Pharma SWOT Analysis

Strengths22

Weakness6

Opportunity4

Threats0

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Affordable stocks with good momentum and ROE - All Stocks (subscription)

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

Higher DVM Stocks Among Midcaps and Largecaps

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Bliss GVS Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Feb, 2026	0.5	INTERIM	18 Feb, 2026	Equity Share
24 Jul, 2025	0.5	FINAL	24 Jul, 2025	Equity Share
18 Jul, 2024	0.5	FINAL		Equity Share
12 Jul, 2023	0.5	FINAL		Equity Share
20 Jun, 2022	0.5	FINAL		Equity Share
13 Sep, 2021	0.5	FINAL		Equity Share
17 Sep, 2020	0.5	FINAL		Equity Share
12 Sep, 2019	1	FINAL		Equity Share
14 Aug, 2018	1	FINAL		Equity Share
18 Sep, 2017	0.6	FINAL		Equity Share

Bliss GVS Pharma Stock Comparison

Financials	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Senores Pharmaceuticals Ltd.	Innova Captab Ltd.
Price (₹)	₹8.01	₹101.40	₹115.25	₹601.75	₹783	₹672
% Change	-4.98%	-2.82%	-0.88%	-0.32%	-1.36%	-1.73%
Revenue TTM (₹ Cr)	₹104.12	₹282.74	-	₹488.20	₹588.52	₹1,496.96
Net Profit TTM (₹ Cr)	₹-24.37	₹15.30	-	₹56.90	₹101.60	₹132.41
PE TTM	-2.70	25.70	-	30.60	35.30	29.00
1 Year Return	701	-19.52	28.2	0.75	38.57	-14.33
ROCE	-5.63	-	-	23.87	9.34	14.12

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 59.08

-0.03%

SIGACHI

Sigachi Industries Ltd.

₹ 20.80

-1.70%

WINDLAS

Windlas Biotech Ltd.

₹ 763.95

-0.97%

VINEETLAB

Vineet Laboratories Ltd.

₹ 30.15

-5.87%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 473.00

+0.15%

ZIMLAB

Zim Laboratories Ltd.

₹ 68.25

-2.53%

MEDICO

Medico Remedies Ltd.

₹ 45.94

-3.61%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 180.50

-0.44%

LASA

Lasa Supergenerics Ltd.

₹ 8.30

+3.23%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 308.30

-1.78%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 341.30

-1.98%

ORTINGLOBE

Ortin Global Ltd.

₹ 17.97

-4.97%

BROOKS

Brooks Laboratories Ltd.

₹ 71.00

-2.70%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1897.90

-0.56%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 109.20

ALPA

Alpa Laboratories Ltd.

₹ 65.10

-4.52%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 127.99

-0.05%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 380.40

+1.36%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.25

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 29.92

INDOCO

Indoco Remedies Ltd.

₹ 206.05

+3.12%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 142.25

-3.53%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 615.00

-0.62%

PANACEABIO

Panacea Biotec Ltd.

₹ 336.00

-1.18%

FAQ's on BLISSGVS

What is the current share price of Bliss GVS Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Bliss GVS Pharma Ltd. is ₹ 213.8 on the NSE and ₹ 213.95 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Bliss GVS Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Bliss GVS Pharma Ltd. is approximately ₹ 2227.7 Cr.

What are the PE and PB ratios for Bliss GVS Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bliss GVS Pharma Ltd. is 20.4, and the Price-to-Book (PB) ratio is 2.

What is the 52-Week High and Low for Bliss GVS Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Bliss GVS Pharma Ltd. shares was ₹ 243.9, and the lowest price was ₹ 108.12.

What is the current dividend yield for Bliss GVS Pharma Ltd.?

As of 6 June 2025, the dividend yield for Bliss GVS Pharma Ltd. is 0.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Bliss GVS Pharma Ltd.?

Significant shareholdings in Bliss GVS Pharma Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Bliss GVS Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bliss GVS Pharma Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Bliss GVS Pharma Ltd.?

Bliss GVS Pharma Ltd. last declared a INTERIM dividend of ₹ 0.5 per share for the financial period ending 2026. The record date was set as 2026-02-18, and the payment was/is scheduled around 2026-02-18. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy